outlook

Agilysys raises FY2027 revenue outlook to $374M-$378M with at least 34% subscription growth (NASDAQ:AGYS)

Earnings Call Insights: Agilysys, Inc. (AGYS) Q2 fiscal 2027

Management View

Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

Source link

Dover narrows 2026 outlook toward upper end with 5%-6% organic growth and $10.60-$10.75 adjusted EPS (NYSE:DOV)

Earnings Call Insights: Dover Corporation (DOV) Q3 2026

Management View

  • “Overall, it was a solid quarter. Organic growth accelerated to 7%… Orders were up 16% year-over-year, with growth in all 5 segments. Book-to-bill was 1.03 for the quarter. Our backlog is up 35% versus this time last year… Adjusted

Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

Source link

Integra outlines $1.634B-$1.654B 2026 revenue outlook as Cincinnati disruption extends into Q2 2027 (NASDAQ:IART)

Earnings Call Insights: Integra LifeSciences (IART) Q3 2026

Management View

  • “For the third quarter, we delivered revenue of $411 million, which was at the low end of our guidance range” (CEO, President & Chairman Stuart Essig). “We delivered adjusted earnings per share of $0.59 and generated $96 million of operating

Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

Source link

Intuitive narrows 2026 procedure growth outlook to 14%-15% amid I&A pricing actions targeting 3%-5% per-procedure reduction (NASDAQ:ISRG)

Earnings Call Insights: Intuitive Surgical (ISRG) Q3 2026

Management View

  • CEO David Rosa said Q3 was “a strong quarter for Intuitive with broad-based adoption across our multiport, single-port and Ion platforms,” adding that “total procedures increased 15%, driven by 14% growth in da Vinci procedures and

Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

Source link